Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer
Alexandre R. Zlotta(University of Toronto), Kris Huygen(Institut Scientifique de Santé Publique), Albert Vanonckelen(Erasmus Hospital), Michel de Cock(Erasmus Hospital), Fabienne Jurion, Kamiel Palfliet(Erasmus Hospital), Claude C. Schulman(Université Libre de Bruxelles), Jean‐Paul Van Vooren(Université Libre de Bruxelles), Michael Pirson(Fordham University), Jacques Simon(Institut Pasteur), Annie Drowart(Centre Hospitalier Universitaire Brugmann)
Cited by 39
Related Papers
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
Newborns Develop a Th1-Type Immune Response to <i>Mycobacterium bovis</i> Bacillus Calmette-Guerin Vaccination
|The Journal of Immunology|1999|405
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
|Nature Reviews Urology|2021|154
The consensus molecular classification of muscle-invasive bladder cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2018|153